Roberts David B's Form 4 filing
Lemaitre Vascular Inc (LMAT) · filed Mar 2, 2026
- Accession no.
- 0001193125-26-086276
- Filed
- Mar 2, 2026
- Trade date
- Feb 26-27, 2026
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 6 non-derivative transactions and 1 derivative transaction. Open-market sales total $904.0K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Roberts David BCIK 0001365731 | Director, Officer (President and Director) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 26, 2026 | Common Stock | AGrant or awardAcquired | +1,514 | $0.00 | $0 | 26,444 | Direct | |
| Feb 26, 2026 | Common Stock | AGrant or awardAcquired | +146 | $0.00 | $0 | 26,590 | Direct | |
| Feb 26, 2026 | Common Stock | MOption exerciseAcquired | +3 | $0.00F3 | $0 | 26,593 | Direct | |
| Feb 26, 2026 | Common Stock | FTax withholdingDisposed | −134 | $113.69 | −$15,234.46 | 26,456 | Direct | |
| Feb 26, 2026 | Common Stock | FTax withholdingDisposed | −13 | $113.69 | −$1,477.97 | 26,443 | Direct | |
| Feb 27, 2026 | Common Stock | SSaleDisposed | −8,464 | $106.80F6 | −$903,955.2 | 17,979 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 26, 2026 | Common Stock | MOption exerciseDisposed | −3 | $0.00 | $0 | 9.38 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F3
Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis.
Referenced by the price of 1 transaction in Table I.
- F6
The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $105.85 to $107.30. The reporting person undertakes to provide to the issuer, any securityholder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.